BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 7682900)

  • 1. HEA 125 and Ber EP4: two monoclonal anti-epithelial, non-cytokeratin antibodies distinguishing metastatic carcinomas from glial tumors.
    Gottschalk J; Jautzke G; Zimmer C; Cervós-Navarro J
    Clin Neuropathol; 1993; 12(2):68-72. PubMed ID: 7682900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial and melanoma antigens in gliosarcoma. An immunohistochemical study.
    Gottschalk J; Jautzke G; Schreiner C
    Pathol Res Pract; 1992 Feb; 188(1-2):182-90. PubMed ID: 1594490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An immunohistochemical study of the expression of the epithelial antigen Ber-EP4 and other tissue-specific antigens in primary and metastatic brain tumors].
    Korshunov AG; Lakhteeva SV
    Arkh Patol; 1998; 60(6):41-7. PubMed ID: 9949905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoreactivity for cytokeratin and epithelial membrane antigen in leiomyosarcoma.
    Miettinen M
    Arch Pathol Lab Med; 1988 Jun; 112(6):637-40. PubMed ID: 2454091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [HEA125 and BerEP4 in neuro-oncologic differential diagnosis].
    Gottschalk J; Jautzke G; Zimmer C; Paulus W; Cervos-Navarro J
    Pathologe; 1992 Apr; 13(2):95-9. PubMed ID: 1603778
    [No Abstract]   [Full Text] [Related]  

  • 6. [Epithelial markers of 2 cytokeratin-negative small cell bronchial cancers].
    Bohrer MH; Hastka J
    Pathologe; 1991 Jan; 12(1):21-3. PubMed ID: 1708881
    [No Abstract]   [Full Text] [Related]  

  • 7. Heterogeneity of epithelial marker expression in routinely processed, poorly differentiated carcinomas.
    Kamel OW; Rouse RV; Warnke RA
    Arch Pathol Lab Med; 1991 Jun; 115(6):566-70. PubMed ID: 1710100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical markers to distinguish between hemangioblastoma and metastatic clear-cell renal cell carcinoma in the brain: utility of aquaporin1 combined with cytokeratin AE1/AE3 immunostaining.
    Weinbreck N; Marie B; Bressenot A; Montagne K; Joud A; Baumann C; Klein O; Vignaud JM
    Am J Surg Pathol; 2008 Jul; 32(7):1051-9. PubMed ID: 18496143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cytokeratins in gliomas.
    Goswami C; Chatterjee U; Sen S; Chatterjee S; Sarkar S
    Indian J Pathol Microbiol; 2007 Jul; 50(3):478-81. PubMed ID: 17883112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of epithelial and keratin markers in glioblastoma multiforme: an immunohistochemical study.
    Oh D; Prayson RA
    Arch Pathol Lab Med; 1999 Oct; 123(10):917-20. PubMed ID: 10506444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Differential immunohistochemical diagnosis of tumors of the human central nervous system using monoclonal antibodies].
    Vial'tseva IuIu; Bukhvalov IB; Vasilov RG
    Arkh Patol; 1996; 58(2):28-32. PubMed ID: 8712936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokeratin 7 and 20 expression in choroid plexus tumors: utility in differentiating these neoplasms from metastatic carcinomas.
    Gyure KA; Morrison AL
    Mod Pathol; 2000 Jun; 13(6):638-43. PubMed ID: 10874668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of monoclonal antibodies to the epithelial membrane antigen in the diagnosis of human tumors].
    Delektorskaia VV; Ermilova VD; Baryshnikov AIu; Raĭkhlin NT
    Vopr Onkol; 1992; 38(5):562-71. PubMed ID: 1300755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma.
    Loy TS; Calaluce RD; Keeney GL
    Mod Pathol; 1996 Nov; 9(11):1040-4. PubMed ID: 8933513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective immunolabeling of early gestational cytotrophoblast and its neoplastic counterpart by the monoclonal antibody Ber-EP4.
    Babury RA; Moscovic EA
    Histol Histopathol; 1993 Apr; 8(2):323-8. PubMed ID: 8490260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibody Ber-EP4 reliably discriminates between microcystic adnexal carcinoma and basal cell carcinoma.
    Krahl D; Sellheyer K
    J Cutan Pathol; 2007 Oct; 34(10):782-7. PubMed ID: 17880584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative immunohistochemical studies of the histopathology of the breast using monoclonal antibodies Lu-5 and b-12].
    Förster C; Bässler R
    Pathologe; 1991 Mar; 12(2):60-5. PubMed ID: 1711692
    [No Abstract]   [Full Text] [Related]  

  • 18. Uterine adenomatoid tumors: immunohistochemical characteristics with emphasis on Ber-EP4 immunoreactivity and distinction from adenocarcinoma.
    Otis CN
    Int J Gynecol Pathol; 1996 Apr; 15(2):146-51. PubMed ID: 8786204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma.
    Berezowski K; Stastny JF; Kornstein MJ
    Mod Pathol; 1996 Apr; 9(4):426-9. PubMed ID: 8729984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of monoclonal antibodies to glial fibrillary acidic protein in the cytologic diagnosis of brain tumors.
    Chen Y; Zhang YX
    Acta Cytol; 1989; 33(6):922-8. PubMed ID: 2588925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.